Cargando…
Atomoxetine and citalopram alter brain network organization in Parkinson’s disease
Parkinson’s disease has multiple detrimental effects on motor and cognitive systems in the brain. In contrast to motor deficits, cognitive impairments in Parkinson’s disease are usually not ameliorated, and can even be worsened, by dopaminergic treatments. Recent evidence has shown potential benefit...
Autores principales: | Borchert, Robin J, Rittman, Timothy, Rae, Charlotte L, Passamonti, Luca, Jones, Simon P, Vatansever, Deniz, Vázquez Rodríguez, Patricia, Ye, Zheng, Nombela, Cristina, Hughes, Laura E, Robbins, Trevor W, Rowe, James B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924537/ https://www.ncbi.nlm.nih.gov/pubmed/31886460 http://dx.doi.org/10.1093/braincomms/fcz013 |
Ejemplares similares
-
Atomoxetine Enhances Connectivity of Prefrontal Networks in Parkinson's Disease
por: Borchert, Robin J, et al.
Publicado: (2016) -
Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures
por: Ye, Zheng, et al.
Publicado: (2016) -
Atomoxetine restores the response inhibition network in Parkinson’s disease
por: Rae, Charlotte L., et al.
Publicado: (2016) -
Improving Response Inhibition in Parkinson’s Disease with Atomoxetine
por: Ye, Zheng, et al.
Publicado: (2015) -
Improving response inhibition systems in frontotemporal dementia with citalopram
por: Hughes, Laura E., et al.
Publicado: (2015)